January 22, 2016
An Acadia Pharmaceuticals Inc. shareholder has negotiated a $15.75 million settlement to resolve his New York federal court claims that RA Capital Management LLC colluded with two investors to score millions in short-swing profits from the drug company in violation of securities laws, according to a Wednesday letter announcing the deal.